Form EFFECT ProMIS Neurosciences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 22, 2025 4:01 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026
- SES Delivers Solid 9 Months & Q3 2026 Results and Reiterates Full-Year Outlook
- Elong Power Holding Limited (NASDAQ: ELPW) Announces Subsidiary’s Entry into a Three-Year Cooperation Agreement Worth at least RMB2 Billion (～US$300 Million), Achieving a Major Breakthrough in Dom
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
